Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update

Lori Mosca; Carole L. Banka; Emelia J. Benjamin; Kathy Berra; Cheryl Bushnell; Rowena J. Dolor; Theodore G. Ganiats; Antoinette S. Gomes; Heather L. Gornik; Clarissa Gracia; Martha Gulati; Constance K. Haan; Debra R. Judelson; Nora Keenan; Ellie Kelepouris; Erin D. Michos; L. Kristin Newby; Suzanne Oparil; Pamela Ouyang; Mehmet C. Oz; Diana Petitti; Vivian W. Pinn; Rita F. Redberg; Rosalyn Scott; Katherine Sherif; Sidney C. Smith; George Sopko; Robin H. Steinhorn; Neil J. Stone; Kathryn A. Taubert; Barbara A. Todd; Elaine Urbina; Nanette K. Wenger

doi:10.1016/j.jacc.2007.02.020

Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update

Lori Mosca, Carole L. Banka, Emelia J. Benjamin, Kathy Berra, Cheryl Bushnell, Rowena J. Dolor, Theodore G. Ganiats, Antoinette S. Gomes, Heather L. Gornik, Clarissa Gracia, Martha Gulati, Constance K. Haan, Debra R. Judelson, Nora Keenan, Ellie Kelepouris, Erin D. Michos, L. Kristin Newby, Suzanne Oparil, Pamela Ouyang, Mehmet C. OzDiana Petitti, Vivian W. Pinn, Rita F. Redberg, Rosalyn Scott, Katherine Sherif, Sidney C. Smith, George Sopko, Robin H. Steinhorn, Neil J. Stone, Kathryn A. Taubert, Barbara A. Todd, Elaine Urbina, Nanette K. Wenger

School of Medicine

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	1230-1250
Number of pages	21
Journal	Journal of the American College of Cardiology
Volume	49
Issue number	11
DOIs	https://doi.org/10.1016/j.jacc.2007.02.020
State	Published - Mar 20 2007

Keywords

AHA Scientific Statements
cardiovascular diseases
prevention
risk factors
women

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jacc.2007.02.020

Cite this

Mosca, L., Banka, C. L., Benjamin, E. J., Berra, K., Bushnell, C., Dolor, R. J., Ganiats, T. G., Gomes, A. S., Gornik, H. L., Gracia, C., Gulati, M., Haan, C. K., Judelson, D. R., Keenan, N., Kelepouris, E., Michos, E. D., Newby, L. K., Oparil, S., Ouyang, P., ... Wenger, N. K. (2007). Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update. Journal of the American College of Cardiology, 49(11), 1230-1250. https://doi.org/10.1016/j.jacc.2007.02.020

Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women : 2007 Update. / Mosca, Lori; Banka, Carole L.; Benjamin, Emelia J.; Berra, Kathy; Bushnell, Cheryl; Dolor, Rowena J.; Ganiats, Theodore G.; Gomes, Antoinette S.; Gornik, Heather L.; Gracia, Clarissa; Gulati, Martha; Haan, Constance K.; Judelson, Debra R.; Keenan, Nora; Kelepouris, Ellie; Michos, Erin D.; Newby, L. Kristin; Oparil, Suzanne; Ouyang, Pamela; Oz, Mehmet C.; Petitti, Diana; Pinn, Vivian W.; Redberg, Rita F.; Scott, Rosalyn; Sherif, Katherine; Smith, Sidney C.; Sopko, George; Steinhorn, Robin H.; Stone, Neil J.; Taubert, Kathryn A.; Todd, Barbara A.; Urbina, Elaine; Wenger, Nanette K.

In: Journal of the American College of Cardiology, Vol. 49, No. 11, 20.03.2007, p. 1230-1250.

Research output: Contribution to journal › Review article › peer-review

Mosca, L, Banka, CL, Benjamin, EJ, Berra, K, Bushnell, C, Dolor, RJ, Ganiats, TG, Gomes, AS, Gornik, HL, Gracia, C, Gulati, M, Haan, CK, Judelson, DR, Keenan, N, Kelepouris, E, Michos, ED, Newby, LK, Oparil, S, Ouyang, P, Oz, MC, Petitti, D, Pinn, VW, Redberg, RF, Scott, R, Sherif, K, Smith, SC, Sopko, G, Steinhorn, RH, Stone, NJ, Taubert, KA, Todd, BA, Urbina, E & Wenger, NK 2007, 'Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update', Journal of the American College of Cardiology, vol. 49, no. 11, pp. 1230-1250. https://doi.org/10.1016/j.jacc.2007.02.020

Mosca, Lori ; Banka, Carole L. ; Benjamin, Emelia J. ; Berra, Kathy ; Bushnell, Cheryl ; Dolor, Rowena J. ; Ganiats, Theodore G. ; Gomes, Antoinette S. ; Gornik, Heather L. ; Gracia, Clarissa ; Gulati, Martha ; Haan, Constance K. ; Judelson, Debra R. ; Keenan, Nora ; Kelepouris, Ellie ; Michos, Erin D. ; Newby, L. Kristin ; Oparil, Suzanne ; Ouyang, Pamela ; Oz, Mehmet C. ; Petitti, Diana ; Pinn, Vivian W. ; Redberg, Rita F. ; Scott, Rosalyn ; Sherif, Katherine ; Smith, Sidney C. ; Sopko, George ; Steinhorn, Robin H. ; Stone, Neil J. ; Taubert, Kathryn A. ; Todd, Barbara A. ; Urbina, Elaine ; Wenger, Nanette K. / Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women : 2007 Update. In: Journal of the American College of Cardiology. 2007 ; Vol. 49, No. 11. pp. 1230-1250.

@article{7619c4d5518b4872a722bee9b1b73874,

title = "Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update",

keywords = "AHA Scientific Statements, cardiovascular diseases, prevention, risk factors, women",

author = "Lori Mosca and Banka, {Carole L.} and Benjamin, {Emelia J.} and Kathy Berra and Cheryl Bushnell and Dolor, {Rowena J.} and Ganiats, {Theodore G.} and Gomes, {Antoinette S.} and Gornik, {Heather L.} and Clarissa Gracia and Martha Gulati and Haan, {Constance K.} and Judelson, {Debra R.} and Nora Keenan and Ellie Kelepouris and Michos, {Erin D.} and Newby, {L. Kristin} and Suzanne Oparil and Pamela Ouyang and Oz, {Mehmet C.} and Diana Petitti and Pinn, {Vivian W.} and Redberg, {Rita F.} and Rosalyn Scott and Katherine Sherif and Smith, {Sidney C.} and George Sopko and Steinhorn, {Robin H.} and Stone, {Neil J.} and Taubert, {Kathryn A.} and Todd, {Barbara A.} and Elaine Urbina and Wenger, {Nanette K.}",

note = "Funding Information: Writing Group Disclosures Writing Group Member Employment Research Grant Other Research Support Speakers' Bureau/ Honoraria Ownership Interest Consultant/Advisory Board Other Lori Mosca Columbia University NIH (Pfizer † ) (no salary) Cholestech (in kind) ⁎ ; Didexus (in kind) ⁎ ; Lipo Science Inc (in kind) ⁎ Abbott ⁎ ; Fornier ⁎ ; Kos ⁎ ; Merck ⁎ ; Schering-Plough ⁎ None Eli Lilly † ; McNeil ⁎ ; NIH ⁎ ; Novartis ⁎ ; Pfizer ⁎ ; Sanofi-Aventis ⁎ ; Schering-Plough ⁎ ; Unilever ⁎ ; Waterfront Media ⁎ Educational grants to Columbia University from Cholestech ⁎ ; Fact Foundation † ; Organon ⁎ ; Pfizer † ; Reliant † ; Unilever ⁎ ; Waterfront Media ⁎ Carole L. Banka La Jolla Institute for Molecular Medicine None None None None None None Emelia J. Benjamin Boston University School of Medicine None None None None None None Kathy Berra Stanford Center for Research & Disease Prevention None Kos Pharmaceuticals ⁎ None None None None Cheryl Bushnell Duke University Medical Center None None None None None None Rowena J. Dolor Duke University Medical Center None None None None Pfizer ⁎ ; Wyeth ⁎ None Theodore G. Ganiats University of California, San Diego None None None None Pfizer None Antoinette S. Gomes University of California at Los Angeles None None None None None None Heather L. Gornik The Cleveland Clinic Foundation BMS-Sanofi ⁎ ; Pfizer † None None None None None Clarissa Gracia University of Pennsylvania None None None None None None Martha Gulati Northwestern University None None None None None None Constance K. Haan University of Florida None None None None None None Debra R. Judelson Cardiovascular Medical Group of Southern California None None Biovail ⁎ ; Kos ⁎ ; Novartis ⁎ ; Pfizer ⁎ None Novartis ⁎ ; Pfizer ⁎ Expert Witness ⁎ Nora Keenan Centers for Disease Control and Prevention None None None None None None Ellie Kelepouris Temple University School of Medicine None None None None None None Erin D. Michos Johns Hopkins School of Medicine None None None None None None L. Kristin Newby Duke University Medical Center BMS–Sanofi † ; Millennium † ; Schering-Plough † ; Inverness Medical ⁎ ; Roche Diagnostics † BMS–Sanofi ⁎ ; Millennium ⁎ None Biosite ⁎ ; Eli Lilly ⁎ ; Inverness Medical ⁎ ; Proctor & Gamble ⁎ ; Johnson & Johnson ⁎ None Suzanne Oparil University of Alabama, Birmingham Abbott Laboratories ⁎ ; AstraZeneca ⁎ ; Aventis ⁎ ; Biovail ⁎ ; Boehringer Ingelheim ⁎ ; Bristol-Myers Squibb ⁎ ; Forest Laboratories ⁎ ; GlaxoSmithKline ⁎ ; Novartis ⁎ ; Merck & Co ⁎ ; Pfizer ⁎ ; Sankyo Pharma ⁎ ; Sanofi-Synthelabo ⁎ ; Schering-Plough ⁎ None None None Bristol-Myers Squibb ⁎ ; Merck & Co ⁎ ; Pfizer ⁎ ; Sanofi ⁎ ; Novartis ⁎ ; The Salt Institute ⁎ Encysive Pharmaceuticals BOD ⁎ Pamela Ouyang Johns Hopkins Bayview Medical Center None None None None CV Therapeutics ⁎ None Mehmet C. Oz Columbia University None None None None None None Diana Petitti; Ad Hoc Member Kaiser Permanente Southern California National Institutes of Health ⁎ None None None None None Vivian W. Pinn Department of Health and Human Services (NIH) None None None None None None Rita F. Redberg University of California at San Francisco Medical Center None None Estrasorb ⁎ None CV Therapeutics ⁎ None Rosalyn Scott Drew Medical Center, Los Angeles, Calif None None ABC Center for Women's Health Annual Symposium ⁎ None ABC Center for Women's Health ⁎ None Katherine Sherif ‡ Drexel University College of Medicine Novartis † None Novartis ⁎ None None None Sidney C. Smith, Jr University of North Carolina, Chapel Hill None None Bayer ⁎ ; BMS ⁎ ; Sanofi ⁎ None Eli Lilly ⁎ ; GlaxoSmithKline ⁎ ; Merck ⁎ ; Pfizer ⁎ ; Sanofi-Aventis ⁎ AstraZeneca (DSMB) ⁎ George Sopko National Heart, Lung, and Blood Institute None None None None None None Robin H. Steinhorn Children's Memorial Hospital, Chicago, Ill None None None None INO Therapeutics ⁎ None Neil J. Stone Northwestern University, Chicago, Ill None None Abbott ⁎ ; AstraZeneca ⁎ ; Merck ⁎ ; Pfizer ⁎ ; Sanofi ⁎ ; Schering-Plough ⁎ None Abbott ⁎ ; AstraZeneca ⁎ ; Merck ⁎ ; Pfizer ⁎ ; Reliant ⁎ ; Schering-Plough ⁎ ; Sonosite ⁎ None Kathryn A. Taubert American Heart Association None None None None None None Barbara A. Todd University of Pennsylvania None None None None None None Elaine Urbina Cincinnati Children's Hospital None None None None None None Nanette K. Wenger Emory University School of Medicine Eli Lilly † ; AstraZeneca ⁎ ; Pfizer ⁎ None Bristol-Myers Squibb ⁎ ; Eli Lilly ⁎ ; Merck ⁎ ; NitroMed ⁎ ; Novartis ⁎ ; Pfizer ⁎ None BMS ⁎ ; CV Therapeutics † ; Eli Lilly ⁎ ; GSK ⁎ ; Kos Pharmaceuticals ⁎ ; Merck ⁎ ; NitroMed ⁎ ; Pfizer ⁎ ; Sanofi-Aventis ⁎ ; Schering-Plough ⁎ None ",

year = "2007",

month = mar,

day = "20",

doi = "10.1016/j.jacc.2007.02.020",

language = "English (US)",

volume = "49",

pages = "1230--1250",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier USA",

number = "11",

}

TY - JOUR

T1 - Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women

T2 - 2007 Update

AU - Mosca, Lori

AU - Banka, Carole L.

AU - Benjamin, Emelia J.

AU - Berra, Kathy

AU - Bushnell, Cheryl

AU - Dolor, Rowena J.

AU - Ganiats, Theodore G.

AU - Gomes, Antoinette S.

AU - Gornik, Heather L.

AU - Gracia, Clarissa

AU - Gulati, Martha

AU - Haan, Constance K.

AU - Judelson, Debra R.

AU - Keenan, Nora

AU - Kelepouris, Ellie

AU - Michos, Erin D.

AU - Newby, L. Kristin

AU - Oparil, Suzanne

AU - Ouyang, Pamela

AU - Oz, Mehmet C.

AU - Petitti, Diana

AU - Pinn, Vivian W.

AU - Redberg, Rita F.

AU - Scott, Rosalyn

AU - Sherif, Katherine

AU - Smith, Sidney C.

AU - Sopko, George

AU - Steinhorn, Robin H.

AU - Stone, Neil J.

AU - Taubert, Kathryn A.

AU - Todd, Barbara A.

AU - Urbina, Elaine

AU - Wenger, Nanette K.

N1 - Funding Information: Writing Group Disclosures Writing Group Member Employment Research Grant Other Research Support Speakers' Bureau/ Honoraria Ownership Interest Consultant/Advisory Board Other Lori Mosca Columbia University NIH (Pfizer † ) (no salary) Cholestech (in kind) ⁎ ; Didexus (in kind) ⁎ ; Lipo Science Inc (in kind) ⁎ Abbott ⁎ ; Fornier ⁎ ; Kos ⁎ ; Merck ⁎ ; Schering-Plough ⁎ None Eli Lilly † ; McNeil ⁎ ; NIH ⁎ ; Novartis ⁎ ; Pfizer ⁎ ; Sanofi-Aventis ⁎ ; Schering-Plough ⁎ ; Unilever ⁎ ; Waterfront Media ⁎ Educational grants to Columbia University from Cholestech ⁎ ; Fact Foundation † ; Organon ⁎ ; Pfizer † ; Reliant † ; Unilever ⁎ ; Waterfront Media ⁎ Carole L. Banka La Jolla Institute for Molecular Medicine None None None None None None Emelia J. Benjamin Boston University School of Medicine None None None None None None Kathy Berra Stanford Center for Research & Disease Prevention None Kos Pharmaceuticals ⁎ None None None None Cheryl Bushnell Duke University Medical Center None None None None None None Rowena J. Dolor Duke University Medical Center None None None None Pfizer ⁎ ; Wyeth ⁎ None Theodore G. Ganiats University of California, San Diego None None None None Pfizer None Antoinette S. Gomes University of California at Los Angeles None None None None None None Heather L. Gornik The Cleveland Clinic Foundation BMS-Sanofi ⁎ ; Pfizer † None None None None None Clarissa Gracia University of Pennsylvania None None None None None None Martha Gulati Northwestern University None None None None None None Constance K. Haan University of Florida None None None None None None Debra R. Judelson Cardiovascular Medical Group of Southern California None None Biovail ⁎ ; Kos ⁎ ; Novartis ⁎ ; Pfizer ⁎ None Novartis ⁎ ; Pfizer ⁎ Expert Witness ⁎ Nora Keenan Centers for Disease Control and Prevention None None None None None None Ellie Kelepouris Temple University School of Medicine None None None None None None Erin D. Michos Johns Hopkins School of Medicine None None None None None None L. Kristin Newby Duke University Medical Center BMS–Sanofi † ; Millennium † ; Schering-Plough † ; Inverness Medical ⁎ ; Roche Diagnostics † BMS–Sanofi ⁎ ; Millennium ⁎ None Biosite ⁎ ; Eli Lilly ⁎ ; Inverness Medical ⁎ ; Proctor & Gamble ⁎ ; Johnson & Johnson ⁎ None Suzanne Oparil University of Alabama, Birmingham Abbott Laboratories ⁎ ; AstraZeneca ⁎ ; Aventis ⁎ ; Biovail ⁎ ; Boehringer Ingelheim ⁎ ; Bristol-Myers Squibb ⁎ ; Forest Laboratories ⁎ ; GlaxoSmithKline ⁎ ; Novartis ⁎ ; Merck & Co ⁎ ; Pfizer ⁎ ; Sankyo Pharma ⁎ ; Sanofi-Synthelabo ⁎ ; Schering-Plough ⁎ None None None Bristol-Myers Squibb ⁎ ; Merck & Co ⁎ ; Pfizer ⁎ ; Sanofi ⁎ ; Novartis ⁎ ; The Salt Institute ⁎ Encysive Pharmaceuticals BOD ⁎ Pamela Ouyang Johns Hopkins Bayview Medical Center None None None None CV Therapeutics ⁎ None Mehmet C. Oz Columbia University None None None None None None Diana Petitti; Ad Hoc Member Kaiser Permanente Southern California National Institutes of Health ⁎ None None None None None Vivian W. Pinn Department of Health and Human Services (NIH) None None None None None None Rita F. Redberg University of California at San Francisco Medical Center None None Estrasorb ⁎ None CV Therapeutics ⁎ None Rosalyn Scott Drew Medical Center, Los Angeles, Calif None None ABC Center for Women's Health Annual Symposium ⁎ None ABC Center for Women's Health ⁎ None Katherine Sherif ‡ Drexel University College of Medicine Novartis † None Novartis ⁎ None None None Sidney C. Smith, Jr University of North Carolina, Chapel Hill None None Bayer ⁎ ; BMS ⁎ ; Sanofi ⁎ None Eli Lilly ⁎ ; GlaxoSmithKline ⁎ ; Merck ⁎ ; Pfizer ⁎ ; Sanofi-Aventis ⁎ AstraZeneca (DSMB) ⁎ George Sopko National Heart, Lung, and Blood Institute None None None None None None Robin H. Steinhorn Children's Memorial Hospital, Chicago, Ill None None None None INO Therapeutics ⁎ None Neil J. Stone Northwestern University, Chicago, Ill None None Abbott ⁎ ; AstraZeneca ⁎ ; Merck ⁎ ; Pfizer ⁎ ; Sanofi ⁎ ; Schering-Plough ⁎ None Abbott ⁎ ; AstraZeneca ⁎ ; Merck ⁎ ; Pfizer ⁎ ; Reliant ⁎ ; Schering-Plough ⁎ ; Sonosite ⁎ None Kathryn A. Taubert American Heart Association None None None None None None Barbara A. Todd University of Pennsylvania None None None None None None Elaine Urbina Cincinnati Children's Hospital None None None None None None Nanette K. Wenger Emory University School of Medicine Eli Lilly † ; AstraZeneca ⁎ ; Pfizer ⁎ None Bristol-Myers Squibb ⁎ ; Eli Lilly ⁎ ; Merck ⁎ ; NitroMed ⁎ ; Novartis ⁎ ; Pfizer ⁎ None BMS ⁎ ; CV Therapeutics † ; Eli Lilly ⁎ ; GSK ⁎ ; Kos Pharmaceuticals ⁎ ; Merck ⁎ ; NitroMed ⁎ ; Pfizer ⁎ ; Sanofi-Aventis ⁎ ; Schering-Plough ⁎ None

PY - 2007/3/20

Y1 - 2007/3/20

KW - AHA Scientific Statements

KW - cardiovascular diseases

KW - prevention

KW - risk factors

KW - women

UR - http://www.scopus.com/inward/record.url?scp=33947186923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947186923&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2007.02.020

DO - 10.1016/j.jacc.2007.02.020

M3 - Review article

C2 - 17367675

AN - SCOPUS:33947186923

VL - 49

SP - 1230

EP - 1250

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 11

ER -